Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published December 2005 | Supplemental Material
Journal Article Open

Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome)


Johanson-Blizzard syndrome (OMIM 243800) is an autosomal recessive disorder that includes congenital exocrine pancreatic insufficiency, multiple malformations such as nasal wing aplasia, and frequent mental retardation1. We mapped the disease-associated locus to chromosome 15q14–21.1 and identified mutations, mostly truncating ones, in the gene UBR1 in 12 unrelated families with Johanson-Blizzard syndrome. UBR1 encodes one of at least four functionally overlapping E3 ubiquitin ligases of the N-end rule pathway, a conserved proteolytic system whose substrates include proteins with destabilizing N-terminal residues. Pancreas of individuals with Johanson-Blizzard syndrome did not express UBR1 and had intrauterine-onset destructive pancreatitis. In addition, we found that Ubr1-/- mice, whose previously reported phenotypes include reduced weight and behavioral abnormalities, had an exocrine pancreatic insufficiency, with impaired stimulus-secretion coupling and increased susceptibility to pancreatic injury. Our findings indicate that deficiency of UBR1 perturbs the pancreas' acinar cells and other organs, presumably owing to metabolic stabilization of specific substrates of the N-end rule pathway.

Additional Information

© 2005 Nature Publishing Group. Received 28 July; accepted 8 September; published online 20 November 2005. We thank all participating families for making this study possible; A. Diem, E. Dazert and S. Balk for technical assistance; and G. Nürnberg for lod score calculations. This research was supported by grants from the Marohn Foundation of the University of Erlangen-Nuremberg and from the German Research Foundation to M.Z. and A.R., from the German Research Foundation and the Deutsche Krebshilfe to M.M.L. and J.M. and from the US National Institutes of Health and the Ellison Medical Foundation to A.V. and Y.T.K.

Attached Files

Supplemental Material - Fig1.pdf

Supplemental Material - Fig2.pdf

Supplemental Material - Table1.pdf

Supplemental Material - Table2.pdf


Files (1.1 MB)
Name Size Download all
96.8 kB Preview Download
848.5 kB Preview Download
76.0 kB Preview Download
104.0 kB Preview Download

Additional details

August 19, 2023
October 20, 2023